GenScript Unveils Prime Editing Boost with the Broad Institute Deal

PISCATAWAY, N.J., March 19, 2025 /PRNewswire/ — GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology. GenScript has signed a licensing agreement…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.